Home › Funds › Greenbush Financial Group, LLC › REGN

Greenbush Financial Group, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Greenbush Financial Group, LLC reported holding 476 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$361K, representing 0.11% of its reported portfolio and ranking #32 among its reported holdings. Greenbush Financial Group, LLC has disclosed REGN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)476 sh
Reported value held$361.15K
Portfolio Weight0.11%
First reportedQ1 2026
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Greenbush Financial Group, LLC's REGN position evolved

Greenbush Financial Group, LLC first disclosed a stake in REGN in Q1 2026 at 489 shares (US$378K). Across 3 filings, Greenbush Financial Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 476 shares valued at US$361K — a reduction of -7 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 489 $377.53K New
Q2 2026 483 $300.99K Reduce
Q3 2026 476 $361.15K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), LOOMIS SAYLES & CO L P (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Greenbush Financial Group, LLC held REGN?

Greenbush Financial Group, LLC has disclosed REGN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Greenbush Financial Group, LLC's current position in REGN?

As of Q3 2026, Greenbush Financial Group, LLC holds 476 shares of REGN (REGENERON PHARMACEUTICALS), valued at $361.15K, representing 0.11% of its reported portfolio and ranking #32.

Has Greenbush Financial Group, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Greenbush Financial Group, LLC reduced its position in REGN.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, LOOMIS SAYLES & CO L P, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.